NexGel, Inc. (NXGL) vs Regentis Biomaterials Ltd. (RGNT)

NexGel, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Regentis Biomaterials Ltd. is the larger, with a market value of $15.8M against $3.0M — 5.3× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 7 and NexGel, Inc. on 2.

Valuation

Metric NXGL RGNT Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 0.13 — 2.83
P/B 0.28 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 0.30 n/m 3.06
Earnings yield (417.65%) — (1.84%)
Free cash flow yield (217.86%) 0.00% 0.17%

Profitability

Metric NXGL RGNT Medical Instruments & Supplies median
Gross margin 35.08% — 54.62%
Operating margin (44.77%) — 1.64%
Net margin (51.26%) — 0.00%
Free cash flow margin (27.66%) 0.00% 1.61%
Return on equity (117.57%) 0.00% 0.00%
Return on assets (34.21%) 0.00% 0.00%
Return on invested capital (45.29%) 0.00% 0.00%

Growth

Metric NXGL RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 3.38% — 9.20%
EPS growth (last fiscal year) 24.00% (1,504.65%) —
Revenue growth, 5-year CAGR 76.12% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NXGL RGNT Medical Instruments & Supplies median
Debt to equity 0.68 0.00 0.08
Current ratio 0.43 5.62 2.49
Net debt to EBITDA 0.13 0.89 0.83

Dividend

Metric NXGL RGNT Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric NXGL RGNT Medical Instruments & Supplies median
Market cap 2.96m 15.82m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack